Skip to main content
Fig. 3 | BMC Oral Health

Fig. 3

From: The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy

Fig. 3

Results of the receiver-operating characteristic curve analysis evaluating the relationship between osteoradionecrosis prevalence after the concurrent chemoradiotherapy and the pretreatment hemoglobin-to-platelet ratio [Area under the curve (AUC): %73 sensitivity: 76.2%; and specificity: 71.4%]

Back to article page

BMC Oral Health

ISSN: 1472-6831

Contact us